Skip to main content
Top

Drugs

Issue 9/2020

Content (12 Articles)

Understanding Refractory Rheumatoid Arthritis: Implications for a Therapeutic Approach

Andrew R. Melville, Lianne Kearsley-Fleet, Maya H. Buch, Kimme L. Hyrich

Novel Approaches Towards a Functional Cure of HIV/AIDS

Lucia Bailon, Beatriz Mothe, Lance Berman, Christian Brander

Correction to: Novel Approaches Towards a Functional Cure of HIV/AIDS

Lucia Bailon, Beatriz Mothe, Lance Berman, Christian Brander

Immune Checkpoint Blockade in Oncogene-Driven Non-Small-Cell Lung Cancer

Ashwin Somasundaram, Mark A. Socinski, Liza C. Villaruz

Isatuximab: First Approval

Sohita Dhillon

Pemigatinib: First Approval

Sheridan M. Hoy

Selumetinib: First Approval

Anthony Markham, Susan J. Keam

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images